Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Social influences on clinical outcomes of patients with ovarian cancer.

Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Zimmerman MB, Penedo FJ, Lucci JA 3rd, Ganjei-Azar P, Thaker PH, Mendez L, Lubaroff DM, Slavich GM, Cole SW, Sood AK.

J Clin Oncol. 2012 Aug 10;30(23):2885-90. doi: 10.1200/JCO.2011.39.4411. Epub 2012 Jul 16.

2.

Prognostic impact of marital status on survival of women with epithelial ovarian cancer.

Mahdi H, Kumar S, Munkarah AR, Abdalamir M, Doherty M, Swensen R.

Psychooncology. 2013 Jan;22(1):83-8. doi: 10.1002/pon.2058. Epub 2011 Sep 15.

PMID:
21919121
3.

Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Cancer. 2015 Oct 1;121(19):3543-50. doi: 10.1002/cncr.29516. Epub 2015 Jun 10.

4.

Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

García-Sáenz JA, Custodio A, Casado A, Vidart JA, Coronado PJ, Martín M, López-Tarruella S, Puente J, Fernández C, Díaz-Rubio E.

Clin Transl Oncol. 2011 Feb;13(2):121-32. doi: 10.1007/s12094-011-0629-6. Review.

PMID:
21324801
5.

Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.

Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, Davis FG.

J Am Diet Assoc. 2010 Mar;110(3):369-82. doi: 10.1016/j.jada.2009.11.014.

PMID:
20184987
6.

Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.

Sijmons EA, van Lankveld MA, Witteveen PO, Peeters PH, Koot VC, van Leeuwen JS.

Eur J Obstet Gynecol Reprod Biol. 2007 Apr;131(2):203-8. Epub 2006 May 16.

PMID:
16707204
7.

Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

Price MA, Butow PN, Bell ML, deFazio A, Friedlander M, Fardell JE, Protani MM, Webb PM; AOCS—Quality of Life Study Investigators on behalf of the Australian Ovarian Cancer Study Group.

Support Care Cancer. 2016 Jun;24(6):2627-34. doi: 10.1007/s00520-015-3070-5. Epub 2016 Jan 6.

PMID:
26732767
8.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD008765. doi: 10.1002/14651858.CD008765.pub3. Review.

PMID:
23450588
9.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
10.
11.

Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.

Muraji M, Sudo T, Iwasaki S, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Nishimura R.

Gynecol Oncol. 2013 Dec;131(3):531-4. doi: 10.1016/j.ygyno.2013.09.030. Epub 2013 Oct 4.

PMID:
24096109
12.

Social support, psychological distress, and natural killer cell activity in ovarian cancer.

Lutgendorf SK, Sood AK, Anderson B, McGinn S, Maiseri H, Dao M, Sorosky JI, De Geest K, Ritchie J, Lubaroff DM.

J Clin Oncol. 2005 Oct 1;23(28):7105-13.

PMID:
16192594
13.

Green tea consumption enhances survival of epithelial ovarian cancer.

Zhang M, Lee AH, Binns CW, Xie X.

Int J Cancer. 2004 Nov 10;112(3):465-9.

14.

The survival detriment of venous thromboembolism with epithelial ovarian cancer.

Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN.

Gynecol Oncol. 2014 Jul;134(1):73-7. doi: 10.1016/j.ygyno.2014.04.046. Epub 2014 May 1.

PMID:
24793732
15.

Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs.

Butow PN, Price MA, Bell ML, Webb PM, deFazio A; Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study Quality Of Life Study Investigators, Friedlander M.

Gynecol Oncol. 2014 Mar;132(3):690-7. doi: 10.1016/j.ygyno.2014.01.002. Epub 2014 Jan 11.

PMID:
24423880
16.

Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer?

Lydiksen L, Jensen-Fangel S, Blaakaer J.

Gynecol Oncol. 2014 Jun;133(3):454-9. doi: 10.1016/j.ygyno.2014.04.004. Epub 2014 Apr 12.

PMID:
24726613
17.

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.

Kolomeyevskaya NV, Szender JB, Zirpoli G, Minlikeeva A, Friel G, Cannioto RA, Brightwell RM, Grzankowski KS, Moysich KB.

Int J Gynecol Cancer. 2015 Nov;25(9):1587-92. doi: 10.1097/IGC.0000000000000540.

18.

Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.

Liu P, Wang Y, Tong L, Xu Y, Zhang W, Guo Z, Ni H.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1163-71. doi: 10.1007/s00280-015-2900-y. Epub 2015 Nov 5.

PMID:
26542279
19.

Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.

Lee JY, Kim TH, Suh DH, Kim JW, Kim HS, Chung HH, Park NH, Song YS, Kang SB.

Eur J Surg Oncol. 2015 Apr;41(4):585-91. doi: 10.1016/j.ejso.2015.01.006. Epub 2015 Jan 17.

PMID:
25624160
20.

Diurnal cortisol and survival in epithelial ovarian cancer.

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20.

Supplemental Content

Support Center